Product Information
JENCYCLA 0.35 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0943 per EA under NDC 68180087773. Its NADAC has been published 299 times since Oct 7, 2020.
Strength
.35 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180087773
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NORETHINDRONEApproval Type
Generic (ANDA)
FDA Application
ANDA091323On Market Since
7/7/2020
Pharmacological Classes
Price Statistics
The NADAC for JENCYCLA 0.35 MG TABLET has been published 299 times since Oct 7, 2020, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0943 per EA |
|---|---|
| All-time high | $0.2295 (Apr 14, 2021) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.1229 |
| Average price | $0.1355 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 299 |
| Tracking since | Oct 7, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of JENCYCLA 0.35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JENCYCLA 0.35 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0943 per EA (NDC 68180087773), effective Jun 24, 2026.
How has the price of JENCYCLA 0.35 MG TABLET changed over time?
Over the history we have for it, the NADAC for JENCYCLA 0.35 MG TABLET has declined 55.9%. It has been tracked across 299 weekly CMS publications since Oct 7, 2020.
What are the highest and lowest recorded NADAC prices for JENCYCLA 0.35 MG TABLET?
Since Oct 7, 2020, the NADAC for JENCYCLA 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.2295 (Apr 14, 2021), with a median of $0.1229 per EA.
Are there cheaper alternatives to JENCYCLA 0.35 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as JENCYCLA 0.35 MG TABLET, but none are currently priced below it.
Who manufactures JENCYCLA 0.35 MG TABLET?
JENCYCLA 0.35 MG TABLET (NDC 68180087773) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification